Archive

Green light for 12 new medicines from EU watchdog

Written by | 8 Apr 2024

The European Medicines Agency (EMA) has recommended the approval of twelve new products, following reviews by its key human medicines committee (CHMP). This brings to twenty-five the number […]

US drug approvals 2010-2019 align with US, but not global, burden of disease; expedited approval programs may make the gap worse

Written by | 17 Mar 2024

Drug approvals in the United States between 2010-2019 were aligned with the US, but not global, burden of disease and the increasing number of expedited drug approvals could […]

BU researchers describe new technological platform to accelerate drug development

Written by | 29 Feb 2024

Drug development is currently an extremely long, expensive and inefficient process. Findings generated in a lab are often very hard to replicate once translated into animal models or […]

Accelerating how new drugs are made with machine learning

Written by | 16 Jan 2024

Researchers have developed a platform that combines automated experiments with AI to predict how chemicals will react with one another, which could accelerate the design process for new […]

Using AI to create better, more potent medicines

Written by | 2 Jun 2023

While it can take years for the pharmaceutical industry to create medicines capable of treating or curing human disease, a new study suggests that using generative artificial intelligence […]

Journal of Pharmaceutical Analysis studies shine the light on advancements in pharmaceutical analytical techniques and overcoming chemoresistance

Written by | 1 Jun 2023

Research into new drug development is ongoing at a very fast pace globally. In keeping with newer remedies entering the market, there is a need for optimizing existing […]

University of Limerick, Ireland research could reduce time required to bring new medicines to market

Written by | 12 Jul 2022

Researchers at University of Limerick in Ireland have developed a new modelling approach to pharmaceutical manufacturing that could reduce the time required to bring medicines to market. Professor […]

New AI technology sheds light on drug development

Written by | 20 Feb 2022

Will artificial intelligence (AI) change the traditional trial–and–error drug development process and become a revolutionary force in the pharmaceutical sector? Active learning and interpretable AI are the two […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.